Cargando…

IGFBP2 Drives Regulatory T Cell Differentiation through STAT3/IDO Signaling Pathway in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest malignancies. Elevated regulatory T cell (Treg) infiltration has a potent immunosuppressive function in tumor biology, which contributes to low survival in PDAC. Nonetheless, the crosstalk between malignant cells and tumor-infil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Longhao, Zhang, Yang, Yang, Tiantian, Chen, Junhang, Zhang, Xuebin, Liang, Xiaoyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785430/ https://www.ncbi.nlm.nih.gov/pubmed/36556226 http://dx.doi.org/10.3390/jpm12122005

Ejemplares similares

MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype
por: Yang, Tiantian, et al.
Publicado: (2023)

Crosstalk between autophagy and immune cell infiltration in the tumor microenvironment
por: Yang, Tiantian, et al.
Publicado: (2023)

Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
por: Cheng, J-t, et al.
Publicado: (2016)

Cyclin G2 Inhibits Oral Squamous Cell Carcinoma Growth and Metastasis by Binding to IGFBP3 and Regulating the FAK-SRC-STAT Signaling Pathway
por: Wang, Danning, et al.
Publicado: (2020)

IGFBP2 potentiates nuclear EGFR-STAT3 signaling
por: Chua, Corrine Yingxuan, et al.
Publicado: (2015)

IGFBP2 drives epithelial-mesenchymal transition in hepatocellular carcinoma via activating the Wnt/β-catenin pathway
por: Chen, Xiu, et al.
Publicado: (2023)

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses
por: Merlo, Lauren M. F., et al.
Publicado: (2020)

IGFBP2 promotes proliferation and cell migration through STAT3 signaling in Sonic hedgehog medulloblastoma
por: Kunhiraman, Haritha, et al.
Publicado: (2023)

Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways
por: Xiang, Zhen, et al.
Publicado: (2021)

Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis
por: Williams, Richard O.
Publicado: (2013)

Targeting the STAT5A/IDO1 axis overcomes radioresistance and reverses the immunosuppressive tumor microenvironment in NSCLC
por: Yang, Yang, et al.
Publicado: (2022)

The Coevolution of IDO1 and AhR in the Emergence of Regulatory T-Cells in Mammals
por: Grohmann, Ursula, et al.
Publicado: (2015)

Astragaloside IV Inhibits the Proliferation of Human Uterine Leiomyomas by Targeting IDO1
por: Qiu, Tiantian, et al.
Publicado: (2022)

Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting
por: Huang, Xiu-yan, et al.
Publicado: (2016)

Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis
por: Lee, Ying-Ying, et al.
Publicado: (2018)

Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor
por: Duan, Zhenzhen, et al.
Publicado: (2020)

Targeting the IDO1 pathway in cancer: from bench to bedside
por: Liu, Ming, et al.
Publicado: (2018)

Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer
por: Thomas, Divya, et al.
Publicado: (2020)

IDO/kynurenine pathway in cancer: possible therapeutic approaches
por: Abd El-Fattah, Eslam E.
Publicado: (2022)

Erratum to: Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting
por: Huang, Xiu-yan, et al.
Publicado: (2016)

Impact of IDO1 and IDO2 on the B Cell Immune Response
por: Merlo, Lauren M. F., et al.
Publicado: (2022)

Electroacupuncture Relieves LPS-Induced Depression-Like Behaviour in Rats Through IDO-Mediated Tryptophan-Degrading Pathway
por: Zhang, Kun, et al.
Publicado: (2020)

Comprehensive Analysis of IGFBPs as Biomarkers in Gastric Cancer
por: Liu, Qi, et al.
Publicado: (2021)

High baseline tumor burden‐associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2‐STAT3‐PD‐L1 pathway
por: Wen, Zhaowei, et al.
Publicado: (2023)

Extracellular matrix stiffness aggravates urethral stricture through Igfbp3/Smad pathway
por: Li, Kaixuan, et al.
Publicado: (2023)

Hypoxic preconditioning protects against ischemic kidney injury through the IDO1/kynurenine pathway
por: Torosyan, Rafael, et al.
Publicado: (2021)

The Anticancer Effects of Atractylenolide III Associate With the Downregulation of Jak3/Stat3-Dependent IDO Expression
por: Liu, Jun-bao, et al.
Publicado: (2020)

Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer
por: Fan, Xuhui, et al.
Publicado: (2021)

1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis
por: Wei, Chunyan, et al.
Publicado: (2016)

Pancreatic Islet Transplants and IDO: When Starving the Enemy Does You Good
por: Crisa, Laura
Publicado: (2010)

Circulating Antibodies to IDO/THO Pathway Metabolites in Alzheimer's Disease
por: Duleu, S., et al.
Publicado: (2010)

Unbalanced IDO1/IDO2 Endothelial Expression and Skewed Keynurenine Pathway in the Pathogenesis of COVID-19 and Post-COVID-19 Pneumonia
por: Chilosi, Marco, et al.
Publicado: (2022)

IDO1 facilitates esophageal carcinoma progression by driving the direct binding of NF-κB and CXCL10
por: Yao, Wenjian, et al.
Publicado: (2023)

TNF+ regulatory T cells regulate the stemness of gastric cancer cells through the IL13/STAT3 pathway
por: Zhao, Rou, et al.
Publicado: (2023)

Simulation Predicts IGFBP2-HIF1α Interaction Drives Glioblastoma Growth
por: Lin, Ka Wai, et al.
Publicado: (2015)

MUC21 induces the viability and migration of glioblastoma via the STAT3/AKT pathway
por: Wang, Leibo, et al.
Publicado: (2022)

Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
por: Jin, Li, et al.
Publicado: (2020)

Stat3 Is Important for Follicular Regulatory T Cell Differentiation
por: Wu, Hao, et al.
Publicado: (2016)

CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation
por: Wlodarczyk, Barbara, et al.
Publicado: (2023)

IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype
por: Lee, Alexander, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r58a3a2errlcd9jpltielrn9uk